HH-009
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HH-009, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC [Phase 1, Phase 2]